Tactile Systems Technology, Inc. (TCMD) Q2 2026 Earnings Call Transcript
Tactile Systems Technology, Inc. (TCMD) Q2 2026 Earnings Call Transcript
TCMD - Tactile Systems Technology, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$40.00
DETAILS
HIGH:
$40.00
LOW:
$40.00
MEDIAN:
$40.00
CONSENSUS:
$40.00
UPSIDE:
78.49%
Stock News
Tactile Systems Technology Q2 Earnings Call Highlights
Tactile Systems Technology NASDAQ: TCMD, doing business as Tactile Medical, reported second-quarter revenue growth and higher profitability, led by its lymphedema business, while updating its full-year outlook to reflect temporary inventory effects in its airway-clearance segment.
Tactile Systems Technology (TCMD) Beats Q2 Earnings and Revenue Estimates
Tactile Systems Technology (TCMD) came out with quarterly earnings of $0.34 per share, beating the Zacks Consensus Estimate of $0.14 per share. This compares to earnings of $0.14 per share a year ago.
Tactile Medical to Release Second Quarter of Fiscal Year 2026 Financial Results on August 10, 2026
MINNEAPOLIS, July 21, 2026 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chronic disorders, today announced that second quarter of fiscal year 2026 financial results will be released after the market closes on Monday, August 10, 2026.
Tactile Medical Enters Exclusive U.S. Distribution Agreement with ElastiMed for its MyoSleeve™ Wearable Compression Device for VA and DoD Patients
Discreet, Battery-Powered Device Reaches Patients at Earlier Stages of Disease Progression Discreet, Battery-Powered Device Reaches Patients at Earlier Stages of Disease Progression
Tactile Systems Technology (TCMD) Moves 8.1% Higher: Will This Strength Last?
Tactile Systems Technology (TCMD) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Tactile Medical Launches Next-Generation AffloVest® Airway Clearance Therapy
MINNEAPOLIS, June 02, 2026 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chronic disorders, today announced full commercial launch of its next-generation AffloVest high-frequency chest wall oscillation (HFCWO) therapy system. The next-generation system maintains its indication for use as a treatment option for chronic neuromuscular and respiratory conditions, including cystic fibrosis and bronchiectasis, across pediatric and geriatric populations, while introducing enhancements to patient comfort, ease of use, and connected care capabilities to support long-term therapy adherence.
Tactile Medical to Present at the William Blair 46th Annual Growth Stock Conference
MINNEAPOLIS, May 20, 2026 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chronic disorders, today announced that management will participate in the William Blair 46th Annual Growth Stock Conference, which is being held at the Loews Hotel in Chicago, IL, from June 2-4, 2026. Management will present on Tuesday, June 2, at 9:20 a.m. Central Time.
Should Value Investors Buy Tactile Systems Technology (TCMD) Stock?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Tactile Systems Technology, Inc. (TCMD) Q1 2026 Earnings Call Transcript
Tactile Systems Technology, Inc. (TCMD) Q1 2026 Earnings Call Transcript
Tactile Systems Technology (TCMD) Reports Q1 Loss, Tops Revenue Estimates
Tactile Systems Technology (TCMD) came out with a quarterly loss of $0.08 per share versus the Zacks Consensus Estimate of a loss of $0.07. This compares to a loss of $0.13 per share a year ago.
Tactile Systems Technology, Inc. Reports First Quarter 2026 Financial Results
MINNEAPOLIS, May 04, 2026 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chronic disorders, today reported financial results for the first quarter ended March 31, 2026. First Quarter 2026 Summary and Recent Business Highlights: Total revenue increased 23% year-over-year to $75.3 million Gross margin of 76.5% versus 74% in Q1 2025 Net loss of $1.8 million versus $3.0 million in Q1 2025 Adjusted EBITDA of $3.7 million versus an Adjusted EBITDA loss of $0.3 million in Q1 2025 Expanded AI-enabled order management platform with the implementation of new operational capabilities to execute the Medicare prior authorization requirement for PCDs Repurchased $1.1 million of stock under the Company's share repurchase program Received FDA 510(k) clearance for next-generation AffloVest airway clearance device “We delivered a strong start to 2026, with first quarter revenue growth of 23% year-over-year driven by disciplined execution of our strategic priorities,” said Sheri Dodd, Chief Executive Officer of Tactile Medical.
Tactile Systems Technology (NASDAQ:TCMD) Stock Passes Below 50 Day Moving Average – Should You Sell?
Tactile Systems Technology, Inc. (NASDAQ: TCMD - Get Free Report)'s stock price passed below its 50-day moving average during trading on Wednesday. The stock has a 50-day moving average of $26.94 and traded as low as $24.74. Tactile Systems Technology shares last traded at $24.96, with a volume of 266,117 shares. Analysts Set New Price
Tactile Medical to Release First Quarter of Fiscal Year 2026 Financial Results on May 4, 2026
MINNEAPOLIS, April 20, 2026 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chronic disorders, today announced that first quarter of fiscal year 2026 financial results will be released after the market closes on Monday, May 4, 2026.
Tactile Systems Technology, Inc. (NASDAQ:TCMD) Receives Consensus Rating of “Moderate Buy” from Brokerages
Tactile Systems Technology, Inc. (NASDAQ: TCMD - Get Free Report) has earned a consensus rating of "Moderate Buy" from the seven ratings firms that are covering the firm, MarketBeat reports. Three research analysts have rated the stock with a hold recommendation, three have assigned a buy recommendation and one has given a strong buy recommendation to
Should Value Investors Buy Tactile Systems Technology (TCMD) Stock?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
3 Medical Instrument Stocks Tapping GenAI to Navigate Industry Woes
GMED, TCMD and IRMD tap GenAI to boost diagnostics and workflows, but high costs, regulation gaps and macro pressures still weigh on MedTech growth.
Tactile Systems Technology, Inc. (NASDAQ:TCMD) Receives Consensus Rating of “Moderate Buy” from Analysts
Shares of Tactile Systems Technology, Inc. (NASDAQ: TCMD - Get Free Report) have been given a consensus rating of "Moderate Buy" by the seven brokerages that are presently covering the firm, MarketBeat reports. Three analysts have rated the stock with a hold recommendation, three have given a buy recommendation and one has given a strong buy
Wall Street Analysts See a 41.11% Upside in Tactile Systems Technology (TCMD): Can the Stock Really Move This High?
The average of price targets set by Wall Street analysts indicates a potential upside of 41.1% in Tactile Systems Technology (TCMD). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
Tactile Systems Technology (TCMD) is an Incredible Growth Stock: 3 Reasons Why
Tactile Systems Technology (TCMD) is well positioned to outperform the market, as it exhibits above-average growth in financials.
Price Targets
Tactile Systems price target raised to $40 from $38 at BTIG
$40.00
(was $22.43)
BTIG
Tactile Systems price target raised to $40 from $32 at Lake Street
$40.00
(was $34.13)
Ben Haynor
·
Lake Street
Tactile Systems price target raised to $38 from $36 at BTIG
$38.00
(was $28.05)
BTIG
Tactile Systems price target raised to $42 from $35 at Piper Sandler
$42.00
(was $28.05)
Piper Sandler
Piper Sandler upgrades Tactile Systems to Overweight on favorable risk-reward
$35.00
(was $27.40)
Adam Maeder
·
Piper Sandler
Piper Sandler Upgrades Tactile Systems Technology (TCMD) to Overweight
$35.00
(was $27.40)
Raymond James
Tactile Systems price target raised to $32 from $23.50 at Lake Street
$32.00
(was $22.18)
Lake Street
Tactile Systems Technology (TCMD) PT Raised at Piper Sandler; 'Q3 A Step In The Right Direction'
$20.00
(was $22.02)
Piper Sandler
Tactile Systems upgraded to Buy from Neutral at BTIG
$28.00
(was $15.77)
BTIG
Tactile Systems initiated with a Buy at Lake Street
$23.50
(was $14.50)
Ben Haynor
·
Lake Street
Piper downgrades Tactile Systems to Neutral after 'disappointing" Q1
$14.00
(was $9.71)
Adam Maeder
·
Piper Sandler
BTIG Reiterates Buy Rating on Tactile Systems Technology (TCMD)
$16.00
(was $13.25)
Sean Lavin
·
BTIG